Bank of America Upgrades BioCryst Pharmaceuticals To Neutral
April 20, 2015 at 09:01 AM EDT
Bank of America upgraded BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) from Underperform to Neutral. BioCryst Pharmaceuticals shares ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.